Stocks in Hong Kong surge | JD Health (06618.HK) rises nearly 4% with strategic cooperation with Sinopharm Biotech | Dahe news predicts that the company's first-half performance will exceed expectations.

According to the Wisdom Finance APP, JD Health (06618.HK) is currently up nearly 4%, as of the time of publication, it is up 3.31% to 45.2 Hong Kong dollars, with a trading volume of 385 million Hong Kong dollars.